FATE NASDAQ
Fate Therapeutics, Inc.
1W: +10.5%
1M: +53.3%
3M: +43.8%
YTD: +87.5%
1Y: +127.2%
3Y: -62.8%
5Y: -97.3%
$2.25
+0.15 (+7.14%)
Weekly Expected Move ±23.6%
$1
$1
$2
$2
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$6M
Revenue
-52.6% YoY
$-130M
Net Income
+26.1% YoY
$-108M
Free Cash Flow
+13.6% YoY
-124.6%
Gross Margin
-2540.4%
Op. Margin
-2402.8%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-49.4%
ROA-34.2%
ROIC-135.4%
Valuation
P/E-2.1
P/B1.5
EV/EBITDA-0.1
Leverage
Debt/Equity0.38
Current Ratio5.79
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z-6.68
Beneish M-4.96